-
Ben Franklin Client Micro Interventional Devices Preps for 2013 EU Launch For Transapical Access Device
Structural heart disease firm Micro Interventional Devices Inc. hopes to gain a CE mark and launch its clinical stage Permaseal transmyocardial access and closure device in Europe by the second half of 2013, with a focus on use for big-ticket transapical transcatheter aortic valve replacement procedures. Permaseal, which the company calls the first transapical access device Continue Reading…
Daily Archives:
November 21st, 2012
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.